Here, we demonstrate the critical nature of mitochondrial dynamics in MM cells and suggest how these machineries could be potentially exploited by upregulating CD38 surface levels: we assume that the huge intracellular NAD+ depletion triggered by CD38 upregulation unmasks mitochondria machinery dysfunction, thus making it an actionable vulnerability for MM cells. The gene discussed is CD38; the disease is Miyoshi myopathy.